Chemours (CC) Q3 Earnings and Revenues Top Estimates
Chemours (CC) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.64 per share a year ago.
Earnings Preview: Chemours (CC) Q3 Earnings Expected to Decline
Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks With Over 4% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
ATTENTION The Chemours Company Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / September 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
The Chemours Company Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - CC
NEW YORK, NY / ACCESSWIRE / September 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Lost Money on The Chemours Company(CC)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
Chemours Develops Low GWP Retrofit Approach for Vehicles
CC anticipates its Opteon portfolio to save an estimated 325 million tons of carbon dioxide equivalent by 2025.
Levi & Korsinsky Reminds Shareholders of an Investigation into The Chemours Company (CC) Regarding Potential Securities Fraud Allegations
NEW YORK, NY / ACCESSWIRE / September 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
Levi & Korsinsky Investigates Possible Securities Fraud Violations by The Chemours Company (CC)
NEW YORK, NY / ACCESSWIRE / September 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
The Chemours Company Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - CC
NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Chemours Company ("The Chemours Company") (NYSE:CC) concerning possible violations of federal securities laws. Chemours issued a press release on August 1, 2024, reporting its financial results for the second quarter of 2024.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC
NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
